PTC Therapeutics, Inc. PTCT
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
PTC Therapeutics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for people living with rare and serious disorders. The company’s current portfolio centers on treatments for neurology and metabolism-related rare diseases, with approved therapies and additional prod…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees939
TickerPTCT
Statistics
Market Cap$6.52B
Revenue (TTM)$1.73B
Net Income$682.6M
Net Margin39.4%
EPS$7.78
P/E7.50
P/S7.43
P/B-34.14
EV/EBITDA-332.12
ROE-332.5%
Dividend Yield—
Price$78.64
Data: Twelve Data · Revenue = mcap / P/S